Table 4 Summary of the results of array-CGH profiling of the DNA of primary tumors and respective CNHCs
| Â | Â | Chromosomal aberrations identified by array-CGH | |
|---|---|---|---|
Patient number | Items analysed by array-CGH | Gains | Losses |
14 | Oncocytoma | None detected | 1, 14, 17, 22, Y |
| Â | CNHC-MF (A) | 1p | 9 |
| Â | CNHC-MF (B) | Balanced | Balanced |
| Â | CNHF-UMF (C) | Balanced | Balanced |
16 | Clear cell RCC | 1p, 2p, 5q, 17 | 3p |
| Â | CNHC-MF (D) | Balanced | Balanced |
18 | Cystic nephroma | Not analysed* | Not analysed* |
| Â | CNHC-UMF (C)** | Balanced | Balanced |
| Â | CNHC-UMF (D)** | Balanced | Balanced |
30 | Clear cell RCC** | 5q, 7 | 3p |
| Â | CNHC-UMF (A)** | Balanced | Balanced |
| Â | CNHC-UMF (B)** | Balanced | Balanced |
37 | Papillary RCC | 6p, 7, 16, 17q, 20 | Y |
| Â | CNHC-MF (A) | Balanced | Balanced |
| Â | CNHC-MF (B) | Balanced | Balanced |
| Â | CNHC-MF (C) | Balanced | Balanced |
| Â | CNHC-UMF (D) | None detected | 3p, 4q |